HRAS Mutations Define a Distinct Subgroup in Head and Neck Squamous Cell Carcinoma.
Niamh ColemanKathrina L MarceloJulia F HopkinsNusrat Israr KhanRobyn R DuLingzhi HongEdward ParkBinaifer BalsaraMollie LeoniCurtis R PickeringJeffrey N MyersJohn Victor HeymachLee A AlbackerDavid S HongMaura GillisonXiuning LePublished in: JCO precision oncology (2023)
-mutant in HNSCC is distinct, which may provide insight to future therapeutic combination strategies.